Keywords: fda, oks, expanded, label, cubist, cubicin, food
FDA OKs expanded label for Cubist's Cubicin
Article | 05 June 2006
The US Food and Drug Administration has approved Cubist Pharmaceuticals' supplemental new drug application for Cubicin (daptomycin for injection) as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
